These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Short-term intensive corticotrophin treatment in myasthenia gravis. Liversedge LA Proc R Soc Med; 1971 May; 64(5):492. PubMed ID: 4325184 [No Abstract] [Full Text] [Related]
31. EMG analysis of myasthenic phenomena during the early deterioration and the improvement following ACTH treatment. Gandiglio G; Pinelli P Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):396-7. PubMed ID: 4176561 [No Abstract] [Full Text] [Related]
32. Corticotropin therapy in patients with myasthenia gravis: steroid metabolism, and histology of skeletal muscle and thymus. Namba T; Shapiro MS J Neurol Sci; 1972 Jun; 16(2):165-76. PubMed ID: 4338783 [No Abstract] [Full Text] [Related]
33. The effect of ACTH treatment on lymphocyte subpopulations in patients with myasthenia gravis. Smith E; Hammarstrom L; Möller E; Matell G Neurology; 1976 Oct; 26(10):915-8. PubMed ID: 183167 [TBL] [Abstract][Full Text] [Related]
34. Treatment of myasthenia gravis. Flacke W N Engl J Med; 1973 Jan; 288(1):27-31. PubMed ID: 4347296 [No Abstract] [Full Text] [Related]
35. Corticotropin therapy in myasthenia gravis: indications and limitations. Namba T; Shapiro MS; Brunner NG; Grob D Neurology; 1970 Apr; 20(4):385. PubMed ID: 4327339 [No Abstract] [Full Text] [Related]
36. [On the therapy of myasthenia gravis. (Presentation of a case)]. Henriquet F; Balestra L Minerva Anestesiol; 1970 Apr; 36(4):277-81. PubMed ID: 4320560 [No Abstract] [Full Text] [Related]
37. [On the relationship between negative effects and positive effects of ACTH therapy in myasthenic patients]. Pinelli P; Gandiglio G Riv Neurol; 1968; 38(2):77-84. PubMed ID: 4298338 [No Abstract] [Full Text] [Related]